Scottish footballer graham carey has described himself as “heartbroken” after the death of his partner, Rachel Borthwick, who had been battling an incurable form of breast cancer. Borthwick, a mother of two, first discovered a lump in September 2021 and later travelled to India for treatment because she believed there were no further options in the UK. The family says she died at CK Birla Hospital in Delhi with her parents at her bedside.
Graham Carey: Reaction and messages
The announcement of Rachel Borthwick’s passing was made by graham carey, who referred to her as his “best friend” and paid tribute to her strength in a social-media message. In his statement, he wrote that their children “will always remember how unbelievably strong and brave you have been until the very end, ” and said they could take comfort that their mother was “no longer in any pain and can now rest in peace. “
Carey’s public words framed the immediate family response, emphasizing both personal loss and a desire to protect the children’s memory of their mother. The forward’s connection to two Scottish clubs was noted in the family description of his role; the announcement underlined the private, family-centred nature of the mourning.
Why this matters right now
Rachel Borthwick’s decision to travel to India for treatment is central to the story and raises questions about patient choices when confronting terminal diagnoses. After finding a lump in September 2021 she was diagnosed with an incurable form of breast cancer and believed that options in the UK were exhausted. Her move abroad for care, and the fact that she died while seeking treatment at CK Birla Hospital in Delhi, highlights the lengths some patients pursue in search of hope or additional therapies.
Beyond the personal tragedy, Borthwick had framed her experience as a catalyst for awareness. She said she hoped her story would encourage women to check themselves: “I wanted to use my journey to help people save their own lives, ” she said. Her account included reports of messages from people who had not previously checked themselves until seeing her posts and then discovering lumps of their own. That element situates the family loss within a public-health conversation about self-examination and early detection.
Expert perspectives and testimony from those involved
The narrative available from the family and from Borthwick herself is primarily testimonial. Rachel Borthwick, described in family statements as a mum-of-two, used her messaging to urge regular checks and to recount the outpouring of responses that followed her public updates. graham carey, identified as a Dunfermline forward and an ex St Johnstone star in family references, conveyed the immediate emotional aftermath and the children’s future memory of their mother.
The clinical detail released publicly is limited to the characterisation of the disease as an incurable form of breast cancer and the fact of treatment sought in India. The location of death, CK Birla Hospital in Delhi, and the presence of Borthwick’s parents at her bedside are among the few confirmed facts available from the family statements.
Given the constrained factual record, institutional commentary or additional clinical perspective has not been provided in public family statements. The choices described by the family—relocating treatment internationally and sharing personal health updates publicly—underscore how individual decisions intersect with larger conversations about access, hope and patient agency when confronted with terminal diagnoses.
This is a private family bereavement with a public dimension: Borthwick used her platform to encourage checks that may have led others to detect lumps sooner, while Carey’s announcement has centred the story on grief and the wellbeing of their children.
As the family and club circles absorb the loss, questions persist about how stories like this might change behaviour around self-checks and how healthcare pathways are perceived by patients confronting limited options. graham carey’s public tribute closes one chapter of a difficult journey; it also opens a public conversation about detection, treatment choices and the human cost of incurable disease.
What will families and clinicians take from this loss, and how will Rachel Borthwick’s public appeal affect women’s screening choices going forward?
